MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$33,441K
EPS
-$2.15
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue-License
--0 -
Total revenue
--650* 0 1,300
Research and development
25,217 36,825* 28,535 22,267
General and administrative
5,710 5,749* 5,277 6,422
Total operating expenses
30,927 42,573* 33,812 28,689
Loss from operations
-30,927 -43,223* -33,812 -27,389
Gain related to transaction with acquirer
-0* 0 0
Interest expense
3,509 2,713* 3,181 3,141
Interest income
1,007 1,689* 1,783 2,124
Other income (expense), net
-12 57* -46 -246
Total other expense
-2,514 -967* -1,444 -1,263
Loss before income tax expense
-33,441 -44,191* -35,256 -28,652
Provision for income taxes
0 -1* 0 2
Net loss
-33,441 -44,190 -35,256 -28,654
Basic EPS
-2.15 -2.848 -2.28 -1.85
Diluted EPS
-2.15 -2.848 -2.28 -1.85
Basic Average Shares
15,585,000 15,515,000 15,478,000 15,468,000
Diluted Average Shares
15,585,000 15,515,000 15,478,000 15,468,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$33,441K Loss before incometax expense-$33,441K Loss from operations-$30,927K Total other expense-$2,514K Interest income$1,007K Total operatingexpenses$30,927K Interest expense$3,509K Other income(expense), net-$12K Research and development$25,217K General andadministrative$5,710K

Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX)